1、Wang K, Wang P, Shi J, Zhu X, He M, Jia X, Yang X, Qiu F, Jin W, Qian M, Fang H, Mi J, Yang X, Xiao H, Minden M, Du Y, Chen Z, Zhang J. . PML/RARalpha targets promoter regions containing PU.1 consensus and RARE half sites in acute promyelocytic leukemia. . Cancer Cell,2010;17(2):186-97
2、Yang S, Dong Q, Yao M, Shi M, Ye J, Zhao L, Su J, Gu W, Xie W, Wang K, Du Y, Li Y, Huang Y.. Establishment of an experimental human lung adenocarcinoma cell line SPC-A-1BM with high bone metastases potency by (99m)Tc-MDP bone scintigraphy.. Nucl Med Biol.,2009;36(3):313-21
3、Wang K, Fang H, Xiao D, Zhu X, He M, Pan X, Shi J, Zhang H, Jia X, Du Y, Zhang J. . Converting Redox Signaling to Apoptotic Activities by Stress-responsive Regulators HSF1 and NRF2 in Fenretinide Treated Cancer Cells.. . PLoS ONE,2009;4(10):e7538
4、Fu S, Zhao H, Shi J, Abzhanov A, Crawford K, Ohno-Machado L, Zhou J, Du Y, Kuo WP, Zhang J, Jiang M, Jin JG. . Peripheral arterial occlusive disease: global gene expression analyses suggest a major role for immune and inflammatory responses. . BMC Genomics.,2008;9:369-369
5、Du YZ, Wang KK, Fang H, Li JM, Xiao DK, Zheng PZ, Chen YL, Fan HY, Pan XL, Zhao CJ, Zhang QH, IMBEAUD S, GRAUDENS E, EVENO E, AUFFRAY C, Chen SJ, Chen Z and Zhang J. . Coordination of Intrinsic, Extrinsic and Endoplasmic Reticulum-Mediated Apoptosis by Imatinib Mesylate Combined with Arsenic Trioxide in Chronic Myeloid Leukemia.. Blood,2006;107(4):1582-1590
6、Zheng PZ, Wang KK, Zhang QY, Huang QH, Du YZ, Zhang QH, Xiao DK, Shen SH, Imbeaud S, Eveno E, Zhao CJ, Chen YL, Fan HY, Waxman S, Auffray C, Jin G, Chen SJ, Chen Z, Zhang J. . Systems analysis of transcriptome and proteome in retinoic acid/arsenic trioxide combination-Induced cell differentiation/apoptosis of acute promyelocytic leukemia.. PNAS,2005;102:7653-7658
7、Yin T, Wu YL, Sun HP, Sun GL, Du YZ, Wang KK, Zhang J, Chen GQ, Chen SJ, Chen Z. . Combined effects of As4S4 and imatinib on chronic myeloid leukemia cells and BCR-ABL oncoprotein.. BLOOD,2004;104(13):4219-25
|
